文献速递烧伤

烧伤患者静脉血栓栓塞预防:创伤剂量低分子肝素时代的12年回顾性队列研究

Venous thromboembolism prophylaxis in burn patients: A 12-year retrospective cohort study in the era of "trauma dosing" low molecular weight heparin.
PubMed 文献 · Burns · 2026-08-08

该12年回顾性队列研究纳入2012至2023年单中心1056例成人烧伤患者,在近乎普遍药物预防下,临床显著静脉血栓栓塞总体发生率为1.8%,随烧伤严重程度递增,>20%TBSA者达7.4%。年龄增加和ICU住院时间延长与静脉血栓栓塞独立相关。

要点

  • 烧伤患者临床显著静脉血栓栓塞总体发生率为1.8%。
  • >20%TBSA烧伤患者静脉血栓栓塞发生率升至7.4%。
  • 年龄增加和ICU住院时间延长与静脉血栓栓塞独立相关。

核心结论

  • 在近乎普遍接受药物预防的现代烧伤人群中,临床显著静脉血栓栓塞发生率较低。
  • 研究结果支持对住院烧伤患者进行持续预防,并提示需前瞻性研究优化风险分层和给药策略。

研究设计与样本

  • 12年单中心回顾性队列研究,纳入2012至2023年成人烧伤患者。
  • 共1056例患者符合纳入标准,平均年龄54.7岁,平均烧伤总面积8.1%。
  • 主要结局为影像学确诊的肺栓塞或腘静脉以上深静脉血栓形成的临床显著静脉血栓栓塞。
  • 采用单因素和多因素logistic回归分析与静脉血栓栓塞相关的因素。

主要发现

  • 静脉血栓栓塞发生率随烧伤严重程度逐步升高,>20%TBSA患者达7.4%。
  • 研究期间静脉血栓栓塞发生率下降,同时机构低分子肝素使用增加,但该下降无统计学显著性。

临床怎么用

  • 对住院烧伤患者应持续进行静脉血栓栓塞药物预防。
  • 对高龄、ICU住院时间延长及>20%TBSA的烧伤患者应加强静脉血栓栓塞风险评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Venous thromboembolism is a recognized complication of burn injury, yet the contemporary incidence in the setting of routine pharmacologic prophylaxis remains uncertain. We conducted a twelve-year retrospective cohort study of adult patients admitted to a single academic burn center between 2012 and 2023. The primary outcome was clinically significant venous thromboembolism, defined as pulmonary embolism or deep vein thrombosis above the popliteal vein confirmed by imaging. Univariable and multivariable logistic regressions were performed to identify factors associated with venous thromboembolism. A total of 1056 patients met inclusion criteria. The mean age was 54.7 years, and the mean total body surface area (TBSA) burned was 8.1%. Nineteen patients developed clinically significant venous thromboembolism, corresponding to an overall incidence of 1.8%. Incidence increased stepwise with burn severity, reaching 7.4% among patients with greater than 20% TBSA. Increasing age (1.01, 1.00-1.06) and intensive care unit length of stay (1.02, 1.00-1.03) were independently associated with venous thromboembolism on multivariable analysis. Over the study period, venous thromboembolism incidence decreased, alongside an increase in institutional use of low molecular weight heparin; however, this decline was not statistically significant. In a modern burn population receiving near-universal pharmacologic prophylaxis, the incidence of clinically significant venous thromboembolism was low. These findings support consistent prophylaxis in hospitalized burn patients while highlighting the need for prospective studies to refine risk stratification and dosing strategies.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Edgar MC, Vrouwe SQ, Rubin D, et al. Venous thromboembolism prophylaxis in burn patients: A 12-year retrospective cohort study in the era of "trauma dosing" low molecular weight heparin. Burns. 2026. PMID: 42868679. doi:10.1016/j.burns.2026.108170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。